drugset / Trial / NCT01582698
TBE Seropersistence up to 10 Years After First Booster in Adults
NaSingle-groupOpen-labelPrevention
Summary
The purpose of this study is to evaluate TBE antibody persistence from 7 to 10 years after the first booster TBE vaccination with FSME-IMMUN 0.5ml.
Timeline
- Start
- 2012-04
- Primary completion
- 2015-06
- Completion
- 2015-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | FSME-IMMUN | Vaccine | 0.5 ml | Intramuscular |